Preformulation studies—The next advance in aluminum adjuvant-containing vaccinesHEM, Stanley L; HOGENESCH, Harm; MIDDAUGH, C. Russell et al.Vaccine. 2010, Vol 28, Num 31, pp 4868-4870, issn 0264-410X, 3 p.Article

New indices to characterize powder flow based on their avalanching behaviorSOH, Josephine L. P; LIEW, Celine V; HENG, Paul W. S et al.Pharmaceutical development and technology. 2006, Vol 11, Num 1, pp 93-102, issn 1083-7450, 10 p.Article

PowderPicking: An inexpensive, manual, medium-throughput method for powder dispensingALSENZ, Jochem.Powder technology. 2011, Vol 209, Num 1-3, pp 152-157, issn 0032-5910, 6 p.Article

The characterization of fluidization behavior using a novel multichamber microscale fluid bedRÄSÄNEN, Eetu; RANTANEN, Jukka; MANNERMAA, Jukka-Pekka et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 3, pp 780-791, issn 0022-3549, 12 p.Article

Solubilization and preformulation studies on PG-300995 (an anti-HIV drug)YINGQING RAN; JAIN, Akash; YALKOWSKY, Samuel H et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 2, pp 297-303, issn 0022-3549, 7 p.Article

Preformulation studies on imexonKUEHL, P. J; HOYE, W. L; MYRDAL, P. B et al.Drug development and industrial pharmacy. 2006, Vol 32, Num 6, pp 687-697, issn 0363-9045, 11 p.Article

Polymorphism and Solvatomorphism 2006BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2008, Vol 97, Num 9, pp 3611-3636, issn 0022-3549, 26 p.Article

Polymorphism and solvatomorphism 2005BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2007, Vol 96, Num 4, pp 705-728, issn 0022-3549, 24 p.Article

Polymorphism and Solvatomorphism 2008BRITTAIN, Harry G.Journal of pharmaceutical sciences. 2010, Vol 99, Num 9, pp 3648-3664, issn 0022-3549, 17 p.Article

Aluminum Adjuvant Dose Guidelines in Vaccine Formulation for Preclinical EvaluationsVECCHI, Simone; BUFALI, Simone; SKIBINSKI, David A. G et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 1, pp 17-20, issn 0022-3549, 4 p.Article

Solution behavior of a novel type 1 interferon, interferon-τKATAYAMA, Derrick S; NAYAR, Rajiv; CHOU, Danny K et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 12, pp 2703-2715, issn 0022-3549, 13 p.Article

Cyclodextrins as Functional Excipients: Methods to Enhance Complexation EfficiencyLOFTSSON, Thorsteinn; BREWSTER, Marcus E.Journal of pharmaceutical sciences. 2012, Vol 101, Num 9, pp 3019-3032, issn 0022-3549, 14 p.Article

Developability Index: A Rapid In Silico Tool for the Screening of Antibody Aggregation PropensityLAUER, Timothy M; AGRAWAL, Neeraj J; CHENNAMSETTY, Naresh et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 1, pp 102-115, issn 0022-3549, 14 p.Article

Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristicsHICKEY, Anthony J; MANSOUR, Heidi M; TELKO, Martin J et al.Journal of pharmaceutical sciences. 2007, Vol 96, Num 5, pp 1282-1301, issn 0022-3549, 20 p.Article

Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum modelCARINO, Stephen R; SPERRY, David C; HAWLEY, Michael et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 1, pp 116-125, issn 0022-3549, 10 p.Article

Assessment of tableting properties using infinitesimal quantities of powdered medicineURABE, Masakiyo; ITO, Shusei; ITAI, Shigeru et al.International journal of pharmaceutics. 2003, Vol 263, Num 1-2, pp 183-187, issn 0378-5173, 5 p.Article

Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental designMURA, P; FURLANETTO, S; CIRRI, M et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 65-71, issn 0731-7085, 7 p.Article

Solubilization and preformulation of poorly water soluble and hydrolysis susceptible N-epoxymethyl-1,8-naphthalimide (ENA) compoundYUANCAI DONG; WAI KIONG NG; SURANA, Uttam et al.International journal of pharmaceutics. 2008, Vol 356, Num 1-2, pp 130-136, issn 0378-5173, 7 p.Article

Assessment of tableting properties using infinitesimal quantities of powder medicine IIURABE, M; ITO, S; ITAI, S et al.Journal of drug delivery science and technology. 2006, Vol 16, Num 5, pp 357-361, 5 p.Article

Beyond preformulation : an ethnographic perspective on press releases = Au-delà de la préformulation : un regard ethnographique sur les communiqués de presseSLEURS, Kim; JACOBS, Geert.Journal of pragmatics. 2005, Vol 37, Num 8, pp 1251-1273, issn 0378-2166, 23 p.Article

Preformulation Characterization of an Aluminum Salt-Adjuvanted Trivalent Recombinant Protein-Based Vaccine Candidate Against Streptococcus pneumoniaeIYER, Vidyashankara; LEI HU; LIYANACE, Mangala Roshan et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 9, pp 3078-3090, issn 0022-3549, 13 p.Article

Optimization of Release Kinetics from Sustained-Release Formulations using Model-Independent Pharmacokinetic SimulationMADERUELO, Cristina; ZARZUELO, Aranzazu; LANAO, José M et al.Journal of pharmaceutical sciences. 2011, Vol 100, Num 8, pp 3260-3267, issn 0022-3549, 8 p.Article

Dielectric Properties of Pharmaceutical Materials Relevant to Microwave Processing: Effects of Field Frequency, Material Density, and Moisture ContentHENG, Paul W. S; LOH, Z. H; LIEW, Celine V et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 2, pp 941-957, issn 0022-3549, 17 p.Article

Self-Organizing Map Analysis Using Multivariate Data from Theophylline Powders Predicted by a Thin-Plate Spline InterpolationYASUDA, Akihito; ONUKI, Yoshinori; KIKUCHI, Shingo et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 11, pp 4535-4542, issn 0022-3549, 8 p.Article

Developability Assessment in Pharmaceutical Industry: An Integrated Group Approach for Selecting Developable CandidatesSAXENA, Vishal; PANICUCCI, Riccardo; JOSHI, Yatindra et al.Journal of pharmaceutical sciences. 2009, Vol 98, Num 6, pp 1962-1979, issn 0022-3549, 18 p.Article